Beigene Highlights Innovative Hematology Portfolio Across B-Cell Malignancies At ASH 2024
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will share new data across ...